Novel therapies target myasthenia gravis.
Hampton
Tracy
T
D000818:Animals; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009157:Myasthenia Gravis / Q000188:drug therapy*; D009838:Oligodeoxyribonucleotides; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use
D002800:Cholinesterase Inhibitors; C477243:EN101; D007166:Immunosuppressive Agents; D009838:Oligodeoxyribonucleotides; D016376:Oligonucleotides, Antisense; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D003520:Cyclophosphamide